Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Outstanding: 2017-2025

Historic Shares Outstanding for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to $123.3 million.

  • Catalyst Pharmaceuticals' Shares Outstanding rose 3.35% to $123.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $123.3 million, marking a year-over-year increase of 3.35%. This contributed to the annual value of $120.9 million for FY2024, which is 12.84% up from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Shares Outstanding is $123.3 million, which was up 0.72% from $122.4 million recorded in Q2 2025.
  • Catalyst Pharmaceuticals' 5-year Shares Outstanding high stood at $123.3 million for Q3 2025, and its period low was $102.7 million during Q2 2022.
  • For the 3-year period, Catalyst Pharmaceuticals' Shares Outstanding averaged around $115.5 million, with its median value being $118.5 million (2024).
  • Its Shares Outstanding has fluctuated over the past 5 years, first decreased by 0.82% in 2022, then climbed by 12.84% in 2024.
  • Catalyst Pharmaceuticals' Shares Outstanding (Quarterly) stood at $103.0 million in 2021, then climbed by 2.20% to $105.3 million in 2022, then rose by 1.77% to $107.1 million in 2023, then climbed by 12.84% to $120.9 million in 2024, then rose by 3.35% to $123.3 million in 2025.
  • Its Shares Outstanding stands at $123.3 million for Q3 2025, versus $122.4 million for Q2 2025 and $122.0 million for Q1 2025.